NO20084375L - Imidazo[1,2-B]pyridaziner, deres fremstilling og deres anvendelse som GABA reseptorligander - Google Patents

Imidazo[1,2-B]pyridaziner, deres fremstilling og deres anvendelse som GABA reseptorligander

Info

Publication number
NO20084375L
NO20084375L NO20084375A NO20084375A NO20084375L NO 20084375 L NO20084375 L NO 20084375L NO 20084375 A NO20084375 A NO 20084375A NO 20084375 A NO20084375 A NO 20084375A NO 20084375 L NO20084375 L NO 20084375L
Authority
NO
Norway
Prior art keywords
pyridazines
preparation
imidazo
receptor ligands
compounds
Prior art date
Application number
NO20084375A
Other languages
English (en)
Norwegian (no)
Inventor
Antonio Guglietta
Jose Luis Falco
Albert Palomer
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of NO20084375L publication Critical patent/NO20084375L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20084375A 2006-03-29 2008-10-17 Imidazo[1,2-B]pyridaziner, deres fremstilling og deres anvendelse som GABA reseptorligander NO20084375L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06111899A EP1845098A1 (en) 2006-03-29 2006-03-29 Imidazo[1,2-b]pyridazines, their processes of preparation and their use as GABA receptor ligands
PCT/EP2007/052988 WO2007110437A1 (en) 2006-03-29 2007-03-28 Imidazo [1, 2-b] pyridazines, their processes of preparation and their use as gaba receptor ligands

Publications (1)

Publication Number Publication Date
NO20084375L true NO20084375L (no) 2008-10-17

Family

ID=36323447

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084375A NO20084375L (no) 2006-03-29 2008-10-17 Imidazo[1,2-B]pyridaziner, deres fremstilling og deres anvendelse som GABA reseptorligander

Country Status (23)

Country Link
US (2) US8153789B2 (ru)
EP (2) EP1845098A1 (ru)
JP (1) JP5091944B2 (ru)
KR (1) KR20090008275A (ru)
CN (1) CN101448831B (ru)
AR (1) AR060212A1 (ru)
AT (1) ATE471325T1 (ru)
AU (1) AU2007231362B2 (ru)
BR (1) BRPI0709207A2 (ru)
CA (1) CA2647116C (ru)
CY (1) CY1111211T1 (ru)
DE (1) DE602007007203D1 (ru)
DK (1) DK2010536T3 (ru)
ES (1) ES2347182T3 (ru)
HK (1) HK1127917A1 (ru)
MX (1) MX2008012274A (ru)
NO (1) NO20084375L (ru)
PL (1) PL2010536T3 (ru)
PT (1) PT2010536E (ru)
RU (1) RU2486188C9 (ru)
SI (1) SI2010536T1 (ru)
TW (1) TWI403512B (ru)
WO (2) WO2007110437A1 (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2555263A1 (en) * 2004-02-12 2005-09-01 Neurogen Corporation Imidazo-pyridazines, triazolo-pyridazines and related benzodiazepine receptor ligands
US8217177B2 (en) 2006-07-14 2012-07-10 Amgen Inc. Fused heterocyclic derivatives and methods of use
US8198448B2 (en) 2006-07-14 2012-06-12 Amgen Inc. Fused heterocyclic derivatives and methods of use
PE20121506A1 (es) 2006-07-14 2012-11-26 Amgen Inc Compuestos triazolopiridinas como inhibidores de c-met
FR2918061B1 (fr) * 2007-06-28 2010-10-22 Sanofi Aventis Derives de 6-cycloamino-3-(pyridin-4-yl)imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique.
US20100216994A1 (en) * 2007-10-30 2010-08-26 Nihon Medi-Physics Co., Ltd. Use of novel compound having affinity for amyloid, and process for production of the same
US7868001B2 (en) * 2007-11-02 2011-01-11 Hutchison Medipharma Enterprises Limited Cytokine inhibitors
US8492379B2 (en) 2007-12-21 2013-07-23 The University Of Sydney Translocator protein ligands
EP2103614A1 (en) * 2008-03-18 2009-09-23 Santhera Pharmaceuticals (Schweiz) AG Substituted imidazopyrimidine, imidazopyrazine and imidazopyridazine derivatives as melanocortin-4 receptor modulators
AU2009249186B2 (en) * 2008-05-19 2014-05-22 Sunovion Pharmaceuticals Inc. Imidazo [1, 2-a] pyridine compounds as GABA-A receptor modulators
EP2297133B1 (en) 2008-06-25 2017-09-13 Forum Pharmaceuticals Inc. 1, 2 disubstituted heterocyclic compounds
US20100267730A1 (en) * 2008-10-09 2010-10-21 Giuseppe Alvaro Novel compounds
DK2427454T3 (da) * 2009-05-07 2013-06-17 Envivo Pharmaceuticals Inc Heterocykliske phenoxymethylforbindelser
TWI617559B (zh) * 2010-12-22 2018-03-11 江蘇恆瑞醫藥股份有限公司 ２－芳基咪唑并［１，２－ｂ］嗒．２－苯基咪唑并［１，２－ａ］吡啶，和２－苯基咪唑并［１，２－ａ］吡衍生物
UA112028C2 (uk) * 2012-12-14 2016-07-11 Пфайзер Лімітед Похідні імідазопіридазину як модулятори гамка-рецептора
GB201321734D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic Agents

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492382A1 (fr) * 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
DE3542661A1 (de) * 1985-12-03 1987-06-04 Bayer Ag Imidazopyridazinalkensaeureamide, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung
DE8808030U1 (de) * 1987-07-04 1988-11-03 Krones Ag Hermann Kronseder Maschinenfabrik, 8402 Neutraubling Etikettiervorrichtung für Behälter
WO1989001333A1 (en) * 1987-08-07 1989-02-23 The Australian National University IMIDAZO[1,2-b]PYRIDAZINES
CA2285264A1 (en) * 1997-04-25 1998-11-05 Michiyo Gyoten Condensed pyridazine derivatives, their production and use
US6303597B1 (en) * 1998-01-14 2001-10-16 Merck Sharp & Dohme Limited Triazolo-pyridazine derivatives as ligands for GABA receptors
WO2000023450A1 (fr) * 1998-10-21 2000-04-27 Takeda Chemical Industries, Ltd. Derives fusionnes de pyridazine, procede de preparation correspondant et utilisation de ces derives
PL355206A1 (en) * 1999-10-08 2004-04-05 Grunenthal Gmbh Bicyclic imidazo-3-yl-amine derivatives
CA2390919A1 (en) * 1999-11-11 2001-05-17 Takeda Chemical Industries, Ltd. Nose drop containing condensed pyridazine
JP2002371042A (ja) * 2001-06-12 2002-12-26 Takeda Chem Ind Ltd ジアミン化合物、その製造法および用途
BR0308243B1 (pt) * 2002-03-05 2014-08-26 Lilly Co Eli Derivados de purina como inibidores de quinase, seu uso para tratar diabetes e doença de alzheimer, para estimular deposição óssea e inibir gsk-3, bem como formulação farmacêutica compreendendo os referidos derivados
GB0210124D0 (en) * 2002-05-02 2002-06-12 Merck Sharp & Dohme Therapeutic agents
CA2509561A1 (en) * 2002-12-18 2004-07-15 Mallinckrodt Inc. Synthesis of heteroaryl acetamides
ES2222813B1 (es) * 2003-07-24 2005-12-16 Ferrer Internacional, S.A. N-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados.
EP1814880B1 (en) * 2004-11-11 2009-01-28 Ferrer Internacional, S.A. Imidazo[1,2-a]pyridine compounds, compositions, uses and methods related thereto
WO2006083682A2 (en) * 2005-01-28 2006-08-10 H.Lundbeck A/S Polymorphic forms of a gabaa agonist
EP1803722A1 (en) * 2006-01-03 2007-07-04 Ferrer Internacional, S.A. Imidazo[1,2-a]pyridin-3-yl-acetic acid hydrazides, processes for their preparation and pharmaceutical uses thereof
WO2008052733A1 (en) * 2006-10-30 2008-05-08 Novartis Ag Imidazopyridazines as pi3k lipid kinase inhibitors

Also Published As

Publication number Publication date
BRPI0709207A2 (pt) 2011-06-28
US20090176788A1 (en) 2009-07-09
ES2347182T3 (es) 2010-10-26
HK1127917A1 (en) 2009-10-09
DE602007007203D1 (de) 2010-07-29
RU2486188C2 (ru) 2013-06-27
AU2007231362A1 (en) 2007-10-04
SI2010536T1 (sl) 2010-10-29
ATE471325T1 (de) 2010-07-15
RU2008142841A (ru) 2010-05-10
CA2647116A1 (en) 2007-10-04
EP2010536A1 (en) 2009-01-07
EP2010536B1 (en) 2010-06-16
US8153789B2 (en) 2012-04-10
WO2007110437A1 (en) 2007-10-04
MX2008012274A (es) 2008-11-12
AU2007231362B2 (en) 2012-07-19
RU2486188C9 (ru) 2013-08-10
CY1111211T1 (el) 2015-06-11
CN101448831B (zh) 2013-05-01
PL2010536T3 (pl) 2010-11-30
KR20090008275A (ko) 2009-01-21
US20120040979A1 (en) 2012-02-16
WO2007110438A1 (en) 2007-10-04
PT2010536E (pt) 2010-09-03
TW200813062A (en) 2008-03-16
JP5091944B2 (ja) 2012-12-05
CA2647116C (en) 2013-12-31
JP2009531384A (ja) 2009-09-03
AR060212A1 (es) 2008-06-04
DK2010536T3 (da) 2010-10-04
EP1845098A1 (en) 2007-10-17
CN101448831A (zh) 2009-06-03
TWI403512B (zh) 2013-08-01
US8993562B2 (en) 2015-03-31

Similar Documents

Publication Publication Date Title
NO20084375L (no) Imidazo[1,2-B]pyridaziner, deres fremstilling og deres anvendelse som GABA reseptorligander
NO20080393L (no) Halogenerte pyrazolo [1,5-A] pyrimidiner, fremgangsmater, anvendelse som GABA-A reseptorligander, sammensetninger og intermediater
MY183373A (en) Pyridine and pyrazine derivatives as protein kinase modulators
TW200800996A (en) Heterobicyclic pyrazole compounds and methods of use
JO3032B1 (ar) مركبات سبيرو – اوكسندول وإستعمالاتها كعوامل علاجية.
TW200738632A (en) Cannabinoid receptor modulators
AR077975A1 (es) Derivados de pirazol pirimidina y composiciones como inhibidores de cinasa de proteina
JO2629B1 (en) Branched carboxylic acid amides containing thienobirol, carboxylic acid amides containing pyrolithiazole, and the like as kinase inhibitors casein epsilon
CA2706986A1 (en) Aryl and heteroaryl fused imidazo (1,5-a) pyrazines as inhibitors of phosphodiesterase 10
JP6042436B2 (ja) 二重活性Ｈ１インバースアゴニスト／５−ＨＴ２Ａアンタゴニストとしての（チエノ［２，３−ｂ］［１，５］ベンゾオキサゼピン−４−イル）ピペラジン−１−イル化合物
MX2011013016A (es) Derivados de aminopirrolidinona y usos de los mismos.
UA96447C2 (ru) Полиморфные формы (2s)-(4e)-n-метил-5-[3-(5-изопропоксипиридин)ил]-4-пентен-2-амина для лечения расстройств центральной нервной системы
MX2012006962A (es) Inhibidores de la esfingosina quinasa.
EA201200863A1 (ru) Ингибиторы сфингозинкиназы
TN2013000323A1 (en) 9-[4-(3-chlor-2-fluor-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one dimaleate, use thereof as a drug, and production thereof
CA2882525A1 (en) Benzimidazoles as cns active agents
HK1145834A1 (en) Phenylpyrazole derivatives
TW200833665A (en) 1H-quinolin-4-one compounds, processes, uses and compositions
NO20072972L (no) Terapeutiske pyrazolo[3,4-B]pyridiner og indazoler
WO2017119456A1 (ja) せん妄の予防または治療剤
NO20090971L (no) 1H-quinolin-4-on forbindelser med affinitet for GABA-receptoren, fremgangsmater, anvendelser og sammensetninger
MXPA05012081A (es) Derivados de pirimidina sustituidos.
NO20090972L (no) Pyrazolo[1,5-A]pyrimidiner, fremgangsmater, anvendelser og sammensetninger
NO20083304L (no) Imidazo(1,2-A)pyridin-3-yl-eddiksyrehydrazider, fremgangsmater for deres fremstilling og farmasoytiske anvendelser derav
KR20130069646A (ko) 이미다조［１，２－ａ］피리딘 유도체

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application